Applications of a planar electrochemiluminescence platform to support regulated studies of macromolecules: Benefits and limitations in assay range

Journal of Pharmaceutical and Biomedical Analysis

Volumn 51, Issue 3, 2010, Pages 626-632

  Thway, Theingi ^a   Macaraeg, Chris ^a   Calamba, Dominador ^a   Patel, Vimal ^a   Tsoi, Jennifer ^a   Ma, Mark ^a   Lee, Jean ^a   DeSilva, Binodh ^a  

^a AMGEN INC   (United States)

Author keywords

5 Paramter logistic model; Assay validation; Automation; Electrochemiluminescence; Liquid handler

Indexed keywords

ANTIBODY;

ACCURACY; ARTICLE; AUTOMATION; CHEMOLUMINESCENCE; CONTROLLED STUDY; DRUG RESEARCH; ELECTROCHEMOLUMINESCENCE; LIGAND BINDING; MACROMOLECULE; MONKEY; NONHUMAN; PRIORITY JOURNAL; PROCESS OPTIMIZATION; PROTEIN ANALYSIS; QUALITY CONTROL; RAT; REPRODUCIBILITY; SENSITIVITY AND SPECIFICITY; TOXICOKINETICS; VALIDATION PROCESS;

ANIMALS; CHEMILUMINESCENT MEASUREMENTS; CHEMISTRY, PHARMACEUTICAL; ELECTROCHEMICAL TECHNIQUES; MACACA FASCICULARIS; MULTIPROTEIN COMPLEXES; RATS;

EID: 70350578662     PISSN: 07317085     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jpba.2009.09.035     Document Type: Article

References (13)

1. Guidance for Industry: Bioanalytical Method Validation, U.S. Department of Health and Human Services Food and Drug Administration, 2001.
2. Findlay J.W.A., Smith W.C., Lee J.W., et al. Validation of immunoassays for bioanalysis: a pharmaceutical industry perspective. J. Pharma. Biomed. Anal. 21 (2000) 1249-1273
3. Lohstroh P., Laughlin L., Gee N., and Lasley B. Development, validation and application of a chemiluminescent immunoassay for the measurement of circulating chorionic gonadotropin levels in the laboratory macaque. J. Med. Primatol. 36 (2007) 164-169
4. Abellan R., Ventura R., Pichini S., et al. Evaluation of immunoassays for the measurement of erythropoietin (EPO) as an indirect biomarker of recombinant human EPO misuse in sport. J. Pharm. Biomed. Anal. 35 (2004) 1169-1177
5. Cao Y., Smith W.C., and Bowsher R.R. A sensitive chemiluminescent enzyme immunoassay for the bioanalysis of carboxyl-terminal B-chain analogues of human insulin. J. Pharma. Biomed. Anal. 26 (2001) 53-61
6. Moxness M., Tatarewicz S., Weeraratne D., et al. Immunogenicity testing by electrochemiluminescent detection for antibodies directed against therapeutic human monoclonal antibodies. Clin. Chem. 51 (2005) 1983-1985
7. White J.T., Martell L.A., Van Tuyl A., et al. Development, validation, and clinical implementation of an assay to measure total antibody response to naglazyme (galsulfase). AAPS J. 10 (2008) 363-372
8. Zia-Amirhosseini P., Salfi M., Leese P., et al. Pharmacokinetics, pharmacodynamics, and safety assessment of palifermin (rHuKGF) in healthy volunteers. Clin. Pharmacol. Ther. 79 (2006) 558-569
9. Horninger D., Eirikis E., Pendley C., et al. A one-step, competitive electrochemiluminescence-based immunoassay method for the quantification of a fully human anti-TNFα antibody in human serum. J. Pharma. Biomed. Anal. 38 (2005) 703-708
10. DeSilva B., Smith W., Weiner R., et al. Recommendations for the bioanalytical method validation of ligand-binding assays to support pharmacokinetic assessments of macromolecules. Pharm. Res. 20 (2003) 1885-1900
11. J. Wang, J. Laycock, D. Burns, et al. Modular application of laboratory robotics in bioanalytical ligand-binding assays to support drug development, www.aapsj.org/abstracts/NBC_2007/NBC07-000674.PDF.
12. Findlay J., and Dillard R. Appropriate calibration curve fitting in ligand binding assays. AAPS J. 9 (2007) 261-267
13. B. Geist, T. McIntosh, E. Dreher, J. Yohrling, Comparison of ELISA immunoassay formats with a BioVeris electrochemiluminescence immunoassay (ECLIA) for measuring the concentration of a therapeutic monoclonal antibody (TMab) in human serum, www.aapsj.org/abstracts/NBC_2008/NBC08-000674.PDF.